Positions

Vice Chair of Research
Medicine
Baylor College of Medicine
Professor
Medicine
Baylor College of Medicine
Professor
Molecular and Human Genetics
Baylor College of Medicine
Professor
Molecular Physiology and Biophysics
Baylor College of Medicine
Director
The Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory
Baylor College of Medicine
Director
Center for Cardiovascular Disease Prevention
Methodist DeBakey Heart and Vascular Center
Co-Director
Lipid Metabolism and Atherosclerosis Clinic
Houston Methodist Hospital
J. S. Abercrombie Chair - Atherosclerosis and Lipoprotein Research
Baylor College of Medicine
Chief of Cardiology
Medicine
Baylor College of Medicine
Chief of Cardiovascular Research
Medicine
Baylor College of Medicine

Education

Fellowship at Howard Hughes Medical Institute and Institute for Molecular Genetics, Baylor College of Medicine
Clinical Fellowship at Baylor College Of Medicine Affiliate Hospitals
Cardiology
Residency at University Of Texas Southwestern Affiliate Hospitals
Internal Medicine
MD from Baylor College Of Medicine
BA from University Of Texas At Austin
Internship at University of Texas Southwestern Medical School

Certifications

Cardiovascular Disease
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
American Board of Clinical Lipidology

Professional Interests

  • Clinical and translational research in patients with hereditary lipid disorders for the prevention and treatment of cardiovascular disease and genetic epidemiology related to lipids and cardiovascular disease

Professional Statement

Dr. Ballantyne's clinical research is the prevention of atherosclerotic vascular disease. This interest includes pharmacological studies to assess the efficacy and benefits of lipid-lowering drug therapy including trials which utilize ultrasound and MRI to examine the effects of lipid-lowering drugs on the progression of atherosclerosis. As the director of The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory, which serves as the core laboratory for the Atherosclerosis Risk in Communities study, Dr. Ballantyne is studying whether genetic variation in combination with novel biomarkers might be useful in identifying individuals at high risk for cardiovascular disease, the metabolic syndrome, and diabetes. Both genomics and proteomics are being used to identify novel molecules that are increased with atherosclerosis and the metabolic syndrome. In addition, his group is studying how genetic variation modifies the response to lipid therapy with the goal of developing personalized diet, lifestyle, and pharmacotherapy based upon the genetic profile and clinical phenotype.

Selected Publications